Larimar Therapeutics, Inc. (LRMR)

4.79 +0.11 (+2.35%) USD  |  NASDAQ  |  Apr 02, 16:00
4.78 -0.01 (-0.21%) After-Hours: 07:52
More

Larimar Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for LRMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Vir Biotechnology, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
ImmunityBio, Inc. Upgrade
BioRestorative Therapies, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade